KEYS vs OGEN · P/E 57, rev $4.98B vs rev $37.7K
Keysight Technologies Inc (KEYS) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the KEYS and OGEN stock pages for the full models.
Not investment advice.